Author Archive
By Jilian Mincer and Erin McPike NEW YORK/WASHINGTON (Reuters) - Americans want to know what the next U.S. president will do to lower their rising healthcare costs, a priority shared by Republican and Democratic voters and second
WASHINGTON (AP) — The nation's three-decade-old ban on blood donations from gay and bisexual men was formally lifted Monday, but major restrictions will continue to limit who can give blood.
(Reuters) - Drugmaker KaloBios Pharmaceuticals Inc said it fired Martin Shkreli as chief executive on Dec. 17, the day he was arrested on charges of a securities fraud. Shkreli, who has become the poster child for
Mark Soto and Xavier Herbert-Gumbs, face felony drug possession charges after authorities said they found a total of 136 pounds (61.7 kg) of cocaine in their vehicles in the Bronx, according to a statement by the
(Reuters Health) - In a 10-year U.S. study, people who drank coffee regularly were less likely to die of many causes, including heart disease and diabetes, than those who didn't drink coffee at all.The more coffee
By Zeba Siddiqui MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd has been warned by U.S. health regulators for violating manufacturing standards at its Halol plant in India, even as it has been working
While many assessments for autism focus on treating the affected child, the current study tested a new questionnaire designed to take a more nuanced snapshot of the numerous ways raising a child with the condition may impact
By Richard Cowan and Susan Cornwell WASHINGTON (Reuters) - Brushing aside concerns about deepening the budget deficit, U.S. lawmakers approved $1.8 trillion worth of federal spending and tax breaks on Friday in a rare show of
SEATTLE (AP) — More school districts around the U.S. are heeding the advice of scientists who have long said that expecting teens to show up to class before 8 a.m. isn't good for their health or
A privately held French drug developer is taking a rare approach to pricing its drug intended to treat a rare disease. Pharnext SAS, whose drug is the only treatment in a late-stage trial for treating a rare